☆ 4.6 Editorial Material

Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Journal

NATURE REVIEWS CLINICAL ONCOLOGY

Volume 14, Issue 6, Pages 333-334

Publisher

NATURE PUBLISHING GROUP

DOI: 10.1038/nrclinonc.2017.49

Keywords

Funding

Leukemia & Lymphoma society
U.S. National Institutes of Health [R01CA138738-05, PO1CA059350, PO1CA190174-01]
Annual Terry Fox Run for Cancer Research (New York, NY)
Carson Family Charitable Trust
William Lawrence and Blanche Hughes Foundation
Emerald Foundation
Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Journal

NATURE REVIEWS CLINICAL ONCOLOGY

Publisher

NATURE PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies

Journal

NATURE REVIEWS CLINICAL ONCOLOGY

Publisher

NATURE PUBLISHING GROUP

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper